The $80 objective used here is a technical and round-number reference level, not an analyst consensus; ETFs like KXI do not receive individual analyst price targets. KXI trades near roughly $71, just below its 52-week high of $73.65, so reaching $80 implies an upside of approximately 13%.
KXI advanced roughly 10% over the trailing 30 days, climbing from about $65 to near $72 per share. The rally reflects a pronounced rotation into defensive, dividend-paying consumer staples equities.
KXI delivers diversified global exposure to roughly 95 consumer staples companies, while XLP concentrates on about 38 U.S. large-cap names from the S&P 500. XLP is materially cheaper, charging a 0.08% expense ratio versus KXI's approximately 0.39% net expense ratio.
FSTA is a low-cost, U.S.-focused consumer staples fund (0.08% expense ratio), while KXI offers global diversification at a higher 0.38% fee. FSTA is far more concentrated at the top — its three largest holdings account for roughly one-third of assets — whereas KXI spreads weight across U.S. and international giants.
All three funds target U.S. consumer staples, but they use different construction rules: GXPS applies an uncapped market-capitalization approach, IYK tracks a capped index with a healthcare tilt, and RSPS equal-weights its constituents. IYK offers the deepest diversification, holding roughly 54–57 stocks versus RSPS's roughly 36–39 equal-weighted positions, while GXPS concentrates in the sector's largest names.
Three routes to one theme: All three funds target U.S. consumer staples, but they differ sharply in construction — FXG and PBJ are smart-beta (rules-based factor) strategies, while IYK is a traditional cap-weighted index tracker. Cost gap matters: IYK carries the lowest expense ratio at roughly 0.38%, versus about 0.63% for FXG and PBJ — a meaningful structural advantage over longer holding periods.
IYK and VDC are U.S.-only funds, while KXI adds global diversification across roughly 95 holdings and multiple developed markets. VDC is the clear cost leader at 0.09%, versus approximately 0.38% for both IYK and KXI .
FSTA offers the deepest diversification, holding roughly 98 stocks across the full market-capitalization spectrum, while XLP is a concentrated large-cap portfolio of about 37 names and IYK sits between them with roughly 54 holdings. All three track market-cap-weighted consumer staples benchmarks, but each follows a different index: the MSCI USA IMI Consumer Staples 25/50 Index (FSTA), the Russell 1000 Consumer Staples RIC 22.5/45 Capped Index (IYK), and the Consumer Staples Select Sector Index (XLP).
IYK is a market-capitalization-weighted, broad U.S. consumer staples fund with meaningful spillover into healthcare; RSPS is a pure-play, equal-weighted staples strategy concentrated in the S&P 500. IYK's top 10 holdings account for roughly two-thirds of assets, creating heavy single-name concentration in megacaps; RSPS spreads risk more evenly across approximately 38 names.
IYK provides broad U.S. consumer staples exposure across roughly 54 holdings, while PBJ is a more concentrated, rules-based portfolio of roughly 31 food and beverage names. Cost favors IYK : it carries a 0.38% expense ratio versus 0.63% for PBJ , a meaningful gap for long-term holders.
FXG uses a modified equal-dollar weighting and factor-based "AlphaDEX" selection methodology, tilting toward mid-cap and value/growth-scored consumer staples names; IYK is a market-cap-weighted tracker of large-cap staples leaders. Cost structure diverges sharply: FXG carries a 0.63% expense ratio, while IYK charges a more competitive 0.38%.
Both funds are passively managed consumer staples ETFs, but GXPS is a pure-play, uncapped market-cap strategy while IYK uses a capped index with a modest healthcare and materials tilt. GXPS is materially cheaper, with a 0.15% net expense ratio versus roughly 0.37%–0.40% for IYK .
IYK is a U.S.-only, concentrated consumer staples fund with roughly 54 holdings, while KXI offers broader global exposure across roughly 95–110 developed-market companies. Both funds charge a 0.38% expense ratio, but their diversification profiles differ sharply: IYK's top ten positions represent about 66% of assets versus roughly 50% for KXI.
IYK has gained roughly 10.4% over the trailing 30 days, climbing to fresh highs as investors rotated into defensive equities. The advance was driven by a risk-off shift out of artificial intelligence (AI) and semiconductor names into low-beta, cash-generative consumer staples.
Both IYK and VDC are passively managed consumer staples funds, but they track different indexes and deliver meaningfully different exposure profiles. VDC is a near-pure staples portfolio of roughly 100+ holdings, while IYK is more concentrated (about 53 holdings) and layers in notable healthcare and basic materials exposure.
IYK is the iShares U.S. Consumer Staples ETF, so it has no direct analyst price targets; the $86 objective is a fallback target drawn from public discussion, not an analyst consensus. The fund recently traded near $77.35, just below its 52-week high of roughly $78.33, meaning $86 implies an upside of about 11%.
Both FSTA and IYK are passively managed, market-cap-weighted exchange-traded funds (ETFs) targeting U.S. consumer staples, but they track different indexes with meaningfully different portfolios. FSTA holds roughly 100 securities across the full market-cap spectrum, while IYK holds about 54 predominantly large-cap names, making FSTA the more diversified option.
IYK and XLP both target U.S. consumer staples, but XLP is a pure-play sector fund while IYK blends in healthcare distribution and materials names, shifting its risk profile. XLP is materially cheaper, with a 0.08% expense ratio versus roughly 0.38% for IYK , and is far larger and more liquid.
All three funds are passively managed, market-cap-weighted vehicles tracking U.S. consumer staples indexes, but they differ meaningfully in breadth: VDC holds roughly 100+ names, FSTA about 97, and XLP only around 38. Costs are nearly identical at the low end, with FSTA and XLP charging a 0.08% expense ratio versus 0.09% for VDC — a negligible gap for most long-term investors.
All three funds operate in the consumer staples universe, but they use sharply different construction methods: FSTA is a passive, market-cap-weighted index tracker, FXG is a smart-beta (rules-based factor) fund, and PBJ is a thematic food-and-beverage product. Cost efficiency is a decisive differentiator: FSTA charges roughly 0.08% annually, versus about 0.63% for both FXG and PBJ.